Tower Research Capital (TRC)’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9K Buy
6,016
+3,101
+106% +$10.3K ﹤0.01% 3682
2025
Q1
$8.45K Sell
2,915
-1,024
-26% -$2.97K ﹤0.01% 3890
2024
Q4
$14K Sell
3,939
-5,711
-59% -$20.3K ﹤0.01% 3484
2024
Q3
$48.1K Buy
9,650
+7,050
+271% +$35.1K ﹤0.01% 2741
2024
Q2
$6.76K Sell
2,600
-26,593
-91% -$69.1K ﹤0.01% 4543
2024
Q1
$124K Buy
29,193
+24,837
+570% +$106K ﹤0.01% 1711
2023
Q4
$8.8K Sell
4,356
-6,517
-60% -$13.2K ﹤0.01% 4462
2023
Q3
$16.6K Sell
10,873
-3,889
-26% -$5.95K ﹤0.01% 3540
2023
Q2
$24.4K Buy
14,762
+5,480
+59% +$9.04K ﹤0.01% 3183
2023
Q1
$11K Buy
9,282
+4,287
+86% +$5.08K ﹤0.01% 4178
2022
Q4
$5K Sell
4,995
-29,880
-86% -$29.9K ﹤0.01% 4828
2022
Q3
$41K Sell
34,875
-3,264
-9% -$3.84K ﹤0.01% 3334
2022
Q2
$24K Buy
38,139
+13,112
+52% +$8.25K ﹤0.01% 3589
2022
Q1
$65K Buy
25,027
+23,239
+1,300% +$60.4K ﹤0.01% 2516
2021
Q4
$7K Buy
+1,788
New +$7K ﹤0.01% 4887
2021
Q2
Sell
-12,044
Closed -$62K 5446
2021
Q1
$62K Buy
12,044
+7,547
+168% +$38.9K ﹤0.01% 2938
2020
Q4
$24K Sell
4,497
-14,424
-76% -$77K ﹤0.01% 3742
2020
Q3
$92K Buy
18,921
+17,938
+1,825% +$87.2K ﹤0.01% 3202
2020
Q2
$5K Sell
983
-20,639
-95% -$105K ﹤0.01% 4258
2020
Q1
$47K Buy
21,622
+8,172
+61% +$17.8K ﹤0.01% 1314
2019
Q4
$78K Sell
13,450
-16,086
-54% -$93.3K 0.01% 1084
2019
Q3
$94K Buy
+29,536
New +$94K 0.01% 1383
2019
Q2
Sell
-951
Closed -$7K 3629
2019
Q1
$7K Sell
951
-228
-19% -$1.68K ﹤0.01% 2849
2018
Q4
$7K Buy
+1,179
New +$7K ﹤0.01% 2666